Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
SYRS

Syros Pharmaceuticals

$6.51

-0.19 (-2.84%)

07:16
02/14/19
02/14
07:16
02/14/19
07:16
Initiation
Syros Pharmaceuticals initiated at Oppenheimer »

Syros Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
SYRS

Syros Pharmaceuticals

$6.23

0.47 (8.16%)

17:41
01/06/19
01/06
17:41
01/06/19
17:41
Hot Stocks
Syros announces strategic priorities, milestones ahead of JPMorgan conference »

Syros Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

SYRS

Syros Pharmaceuticals

$6.81

-0.22 (-3.13%)

18:11
12/02/18
12/02
18:11
12/02/18
18:11
Hot Stocks
Syros Pharmaceuticals announced data from ongoing Phase 2 Trial of SY-1425 »

Syros Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

Over a quarter ago
SYRS

Syros Pharmaceuticals

$8.03

0.16 (2.03%)

13:00
11/16/18
11/16
13:00
11/16/18
13:00
Recommendations
Syros Pharmaceuticals analyst commentary at Piper Jaffray »

Syros Phase I dose…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 01

    Dec

SYRS

Syros Pharmaceuticals

$7.52

-0.27 (-3.47%)

09:34
11/15/18
11/15
09:34
11/15/18
09:34
Hot Stocks
Syros says data from Phase 1 trial of SY-1365 demonstrates proof-of-mechanism »

Syros Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 01

    Dec

SYRS

Syros Pharmaceuticals

$7.52

0.08 (1.08%)

07:12
11/13/18
11/13
07:12
11/13/18
07:12
Hot Stocks
Syros presents preclinical combination data on SY-1365 »

Syros Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 01

    Dec

SYRS

Syros Pharmaceuticals

$7.80

0.38 (5.12%)

07:20
11/05/18
11/05
07:20
11/05/18
07:20
Upgrade
Syros Pharmaceuticals rating change at Roth Capital »

Syros Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 01

    Dec

SYRS

Syros Pharmaceuticals

$6.58

-0.275 (-4.01%)

07:11
11/01/18
11/01
07:11
11/01/18
07:11
Hot Stocks
Syros Pharmaceuticals existing cash sufficient to fund requirements into 2020 »

Based on its current…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 27

    Nov

SYRS

Syros Pharmaceuticals

$6.58

-0.275 (-4.01%)

07:10
11/01/18
11/01
07:10
11/01/18
07:10
Earnings
Syros Pharmaceuticals reports Q3 EPS (47c), consensus (46c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 27

    Nov

SYRS

Syros Pharmaceuticals

$10.06

-0.135 (-1.32%)

07:38
08/07/18
08/07
07:38
08/07/18
07:38
Hot Stocks
Syros Pharmaceuticals has sufficient cash, cash equivalents to fund into 2020 »

Based on its current…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 14

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.